Rexmyelocel-T for critical limb ischaemia in patients with diabetes mellitus

featured image
Interventions: REX-001 (Rexmyelocel-T)
Therapeutic Areas: Cardiovascular System
Year: 2017

The treatment, rexmyelocel-T, is being developed to relieve leg pain at rest and heal leg ulcers. The treatment uses cells from bone marrow which are injected into the damaged blood vessel, where they restore existing blood vessels and create new blood vessels. By improving the blood flow in the limb, this treatment aims to improve the patient’s condition so that they do not require amputation.